Mr Mrs Miss Ms Dr Other

Dr
Elitsa
Peeva

Patent Director

Glasgow Office

Life sciences

Telephone. +44(0) 141 229 5800
Email. epeeva@hgf.com
Vcard
Linkedin

Experience

Elitsa holds a BSc in Pharmacology and a PhD in Regenerative Medicine. She particularly enjoys working with deep tech SMEs to develop IP strategies that maximise company value and support their commercial objectives. Elitsa has strong expertise in patent drafting, prosecution and landscaping, and is additionally developing her practice in oppositions and appeals. While her primary technical focus is cell and gene therapy, she enjoys supporting clients across a wide range of Life Sciences technologies.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

BSC

Pharmacology

PHD

Regenerative Medicine

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property

Publications

HGF Director Promotions

View publication online

Lack of Unity

View publication online

Mature oligodendrocytes bordering lesions limit demyelination and favor myelin repair via heparan sulfate production

View publication online

Related News

Event - 27th October 2026

HGF sponsors pro-manchester Retail Lunch 2026

HGF is delighted to be sponsoring pro-manchester Retail Lunch 2026, taking place on Tuesday 27 October 2026 at INNSiDE by Meliá in Manchester. As part of the event, HGF Partner …

Event details
HGF

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article
HGF

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article
Event - 12th November 2026

HGF Partners with PPTI for 'Designing Foods for Healthy Aging' Webinar

As healthy aging, metabolic health and weight management rise up the consumer agenda, food and nutrition businesses are increasingly looking beyond traditional product development and towards solutions that deliver measurable …

Event details
Event - 14th October 2026

Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU.

We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. Speaker: Dr Andrew Wells (Partner and …

Event details
Event - 28th October 2026

HGF Attending BMCS Antibody–Drug Conjugates 2026

HGF is pleased to announce that Dr Thomas Lonsdale, Patent Director, will be attending the BMCS Antibody–Drug Conjugates 2026 meeting, taking place on 19 November 2026 at GSK, Stevenage, UK. …

Event details

Hsu Min Chung Recognised in IAM Global Leaders 2027

HGF is delighted to announce that Partner, Hsu Min Chung, has been recognised in the IAM Global Leaders 2027 guide, a prestigious ranking that highlights some of the world’s leading …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us